Osisko Gold Royalties(OR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OR Osisko Gold Royalties

Not Yet Opened 11-21 16:00:00 EST

19.86

+0.02

+0.10%

盘后19.86

+0.000.00%

16:51 EST

High20.02	Low19.69	Vol675.54K
Open20.00	D1 Closing19.84	Amplitude1.66%
Mkt Cap3.71B	Tradable Cap3.69B	Total Shares186.61M
T/O13.39M	T/O Rate0.36%	Tradable Shares185.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"OR","market":"US","secType":"STK","nameCN":"Osisko Gold Royalties","latestPrice":19.86,"timestamp":1732222800000,"preClose":19.84,"halted":0,"volume":675544,"hourTrading":{"tag":"盘后","latestPrice":19.86,"preClose":19.86,"latestTime":"16:51 EST","volume":33644,"amount":668066.50949,"timestamp":1732225869644},"delay":0,"floatShares":185621723,"shares":186612336,"eps":-0.218366,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"11-21 16:00:00 EST","open":20,"high":20.02,"low":19.69,"amount":13394703.996144,"amplitude":0.016633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.218366,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732266000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":19.84,"dividendRate":0.009019,"preHourTrading":{"tag":"盘前","latestPrice":18.82,"preClose":19.84,"latestTime":"08:00 EST","volume":310,"amount":6095.20016,"timestamp":1732194005426},"postHourTrading":{"tag":"盘后","latestPrice":19.86,"preClose":19.86,"latestTime":"16:51 EST","volume":33644,"amount":668066.50949,"timestamp":1732225869644},"volumeRatio":0.48199,"impliedVol":0.4301,"impliedVolPercentile":0.7778},"requestUrl":"/m/hq/s/OR","defaultTab":"news","newsList":[{"id":"2485212409","title":"Osisko Gold Royalties Ltd (OR): A Top Silver Mining Stock to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2485212409","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485212409?lang=en_us&edition=fundamental","pubTime":"2024-11-21 03:27","pubTimestamp":1732130844,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Silver Mining Stocks to Buy Right Now. In this article, we are going to take a look at where Osisko Gold Royalties Ltd  stands against other best silver mining stocks to buy right now.The Silver Institute highlighted that, in 2024, global mined silver production is expected to rise by 1% YoY to 837Moz. This is expected to be supported by growth from Mexico, Chile, and the US, which should outpace lower output from Peru, Argentina, and China. The production from Mexico is expected to rise by 10Moz, which equates to 5% YoY, to 209Moz. This should stem from increased mill throughput and grade at Pan American Silver’s La Colorada operation, following the upgraded ventilation infrastructure. Also, the output is","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vYHskF4hmOZZXTSRcq2uEQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/755fb963a3e7b42a35a1790629b84207","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vYHskF4hmOZZXTSRcq2uEQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/755fb963a3e7b42a35a1790629b84207"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/osisko-gold-royalties-ltd-top-192724199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OR","BK4017"],"gpt_icon":0},{"id":"2485149491","title":"Stryker Stock May Gain From Oculan Lighting Platform's Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2485149491","media":"Zacks","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485149491?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:29","pubTimestamp":1732112940,"startTime":"0","endTime":"0","summary":"Stryker Corporation SYK unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the highest standard of care.The Oculan Lighting Platform excels in providing bright, even light in hard-to-reach spaces, wherein surgeons need it most. The platform’s enhanced contrast capabilities allow surgeons to distinguish between different tissues and anatomical structures more easily.Given the market potential for surgical lighting, SYK’s Oculan Lighting Platform is likely to provide a boost to the company’s business and generate additional revenues. This can further help the stock’s price to rise.The Auto Lux and Microspot features provide uniform brightness and pure white even in harder-to-reach areas such as a deep cavity or small incision procedures. The SHD Mode of the platform allows for the removal of perceived red to improve contrast, tissue differentiation and reduction of glar","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/stryker-stock-may-gain-oculan-142900501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ANGO","LU2468319806.SGD","BK4585","GMED","LU0240877869.USD","LU2089984988.USD","LU1791710582.SGD","LU2362541273.HKD","LU0690374615.EUR","LU2404859741.USD","OR","BK4017","BK4566","BK4504","LU2362541513.USD","GB00B4LPDJ14.GBP","LU1791710400.SGD","LU0240878834.USD","BK4588","LU0114720955.EUR","LU0205193047.USD","LU2065732104.USD","LU2404859667.USD","GB00B4QBRK32.GBP","LU2362540622.SGD","LU0528227936.USD","LU0882574055.USD","MASI","SYK","LU0205194284.USD","IE0009354923.USD","LU0690374961.EUR"],"gpt_icon":1},{"id":"2484627329","title":"iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2484627329","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484627329?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:15","pubTimestamp":1731935700,"startTime":"0","endTime":"0","summary":"Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/18/2982765/0/en/iRhythm-Data-Presented-at-the-American-Heart-Association-2024-Scientific-Sessions-Reinforce-Clinical-and-Health-Economic-Value-of-Zio-Long-Term-Continuous-Monitoring.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4017","BK4563","VT","BK4588","BK4082","BK4585","BK4117","IRTC","OR","AFG"],"gpt_icon":0},{"id":"2483370419","title":"SYK Stock Rises Following the Launch of Next Generation SurgiCount+","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370419","media":"Zacks","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483370419?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:00","pubTimestamp":1731675600,"startTime":"0","endTime":"0","summary":"Stryker Corporation SYK has announced the launch of the next generation of SurgiCount+ within its sponge management portfolio.SurgiCount+, integrated with Stryker’s Triton technology, is likely to provide solutions for retained surgical sponges and blood-loss assessment. Integrating these previously separate digital solutions is likely to provide the added benefit of more efficiency and a streamlined workflow for hospitals.Following the announcement, shares of the company moved nearly 1.6% north to $389.47 in yesterday’s aftermarket trading. In the year-to-date period, SYK shares have rallied 28% compared with the industry’s 13.8% growth. The S&P 500 increased 26% in the same time frame.Meanwhile, SYK currently has a market capitalization of $148.04 billion. It has an earnings yield of 3.1%, higher than the industry’s yield of 1.5%. In the last reported quarter, SYK delivered an earnings surprise of 3.2%.Per a report byFuture Market Insight, the global hemorrhage control market was est","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GmVc8.ZtfGjPFG_U83F8fA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GmVc8.ZtfGjPFG_U83F8fA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/syk-stock-rises-following-launch-130000519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1791710582.SGD","BK4585","BK4567","BK4583","LU0528227936.USD","GB00B4LPDJ14.GBP","BK4566","LU2362540622.SGD","SYK","LU1791710400.SGD","LU2065731478.USD","BK4082","LU0882574055.USD","LU0690374615.EUR","LU2468319806.SGD","LU1854103824.USD","LU0114720955.EUR","BK4504","OR","BK4588","ANGO","GB00B4QBRK32.GBP","LU0690374961.EUR","LU2362541273.HKD","BK4017","LU2089984988.USD","LU2404859741.USD","LU2404859667.USD","BK4196","DGX","LU1854104046.USD","LU2362541513.USD","RDNT"],"gpt_icon":0},{"id":"2483280628","title":"Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment","url":"https://stock-news.laohu8.com/highlight/detail?id=2483280628","media":"PR Newswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483280628?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:05","pubTimestamp":1731593100,"startTime":"0","endTime":"0","summary":"PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker, a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management portfolio. Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals.About StrykerStryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is ava","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/N4XEMVkrMFdhWQYQI6zWiw--~B/aD00MDA7dz0yNjc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/82e07b7e7a4122235a8e91f70018d176","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/N4XEMVkrMFdhWQYQI6zWiw--~B/aD00MDA7dz0yNjc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/82e07b7e7a4122235a8e91f70018d176"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/stryker-launches-next-generation-surgicount-140500618.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/stryker-launches-next-generation-surgicount-140500618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","GB00B4QBRK32.GBP","LU2404859667.USD","LU1791710400.SGD","LU0882574055.USD","LU2362541273.HKD","BK4588","LU0690374615.EUR","LU0528227936.USD","LU2404859741.USD","LU1791710582.SGD","LU0114720955.EUR","BK4017","OR","BK4082","BK4566","LU0690374961.EUR","GB00B4LPDJ14.GBP","SYK","LU2089984988.USD","BK4585","LU2362540622.SGD","LU2362541513.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"1188409665","title":"Stock Track | Osisko Gold Royalties Plunges 5% After Analyst Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=1188409665","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188409665?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:32","pubTimestamp":1731335541,"startTime":"0","endTime":"0","summary":"Shares of Osisko Gold Royalties Ltd.  fell sharply on Friday, plummeting 5.09% to close at $20.12. The sell-off came after TD Cowen downgraded the stock from a \"Buy\" rating to a \"Hold\" rating.In a research note, TD Cowen analysts cited concerns over Osisko's growth prospects and valuation, leading them to lower their rating on the gold royalty company. The downgrade suggests the analysts have a more cautious outlook on the stock's performance moving forward.Analyst downgrades often have a signif","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Osisko Gold Royalties Plunges 5% After Analyst Downgrade","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["OR"],"gpt_icon":0},{"id":"2482720007","title":"TD Cowen Downgrades Osisko Gold Royalties to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2482720007","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482720007?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:08","pubTimestamp":1731326915,"startTime":"0","endTime":"0","summary":"Price: 20.12, Change: -0.20, Percent Change: -0.98","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TD","OR","COWN"],"gpt_icon":0},{"id":"2482451976","title":"Osisko Gold Royalties Ltd reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482451976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482451976?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:48","pubTimestamp":1731102511,"startTime":"0","endTime":"0","summary":"Osisko Gold Royalties Ltd reports results for the quarter ended September 30 - Earnings SummaryOsisko Gold Royalties Ltd OR.TO reported quarterly adjusted earnings of 15 cents per share for the quarte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF3X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OR"],"gpt_icon":0},{"id":"2481394006","title":"Osisko Gold Royalties Ltd (OR) Q3 2024 Earnings Call Highlights: Strong Cash Margins and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481394006","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481394006?lang=en_us&edition=fundamental","pubTime":"2024-11-07 15:26","pubTimestamp":1730964365,"startTime":"0","endTime":"0","summary":"Gold Equivalent Ounces Earned: 18,408 in Q3 2024.Operating Cash Flows: CAD 47.2 million with a cash margin of 96.3%.Cash and Net Debt: CAD 58.5 million in cash and net debt reduced to just over CAD 20 million.Quarterly Revenue: CAD 57.3 million, slightly lower year-over-year.Earnings Per Share: CAD 0.10 per basic share.Adjusted Earnings Per Share: CAD 0.15 per basic common share.Dividend: CAD 0.065 per share, marking the 40th consecutive dividend.Net Debt Reduction: From just under CAD 250 million in Q3 2023 to CAD 22 million in Q3 2024.GuruFocus has detected 8 Warning Signs with OR.Osisko Gold Royalties Ltd  achieved a cash margin of 96.3% in Q3 2024, highlighting its strong profitability.The company earned 18,408 gold equivalent ounces in Q3, positioning it well to meet its full-year guidance of 77,000 to 83,000 gold equivalent ounces.Osisko Gold Royalties Ltd  completed the acquisition of a 1.8% gross revenue royalty on Spartan Resources' Dalgaranga gold project, enhancing its portf","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/SJUyUVmegqQ8kD32XPjH5A--~B/aD0yNDA7dz0yNDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/34156ec763eb2fc7530064c1888e7872","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/SJUyUVmegqQ8kD32XPjH5A--~B/aD0yNDA7dz0yNDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/34156ec763eb2fc7530064c1888e7872"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/osisko-gold-royalties-ltd-q3-072605646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OR"],"gpt_icon":0},{"id":"2481190964","title":"Osisko Gold: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2481190964","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481190964?lang=en_us&edition=fundamental","pubTime":"2024-11-07 07:07","pubTimestamp":1730934459,"startTime":"0","endTime":"0","summary":"MONTREAL  — MONTREAL  — Osisko Gold Royalties Ltd.  on Wednesday reported third-quarter net income of $13.4 million.On a per-share basis, the Montreal-based company said it had profit of 7 cents. Earnings, adjusted for non-recurring costs, were 11 cents per share.The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 11 cents per share.The mining royalty and exploration company posted revenue of $42 million in the period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/osisko-gold-q3-earnings-snapshot-230739334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OR"],"gpt_icon":0},{"id":"2481772957","title":"Osisko Gold Royalties Q3 2024 Adj. EPS $0.15 Beats $0.14 Estimate, Sales $57.300M Miss $59.942M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481772957","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481772957?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:46","pubTimestamp":1730929594,"startTime":"0","endTime":"0","summary":"Osisko Gold Royalties (NYSE:OR) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.14 by 7.14 percent.  The company reported quarterly sales of $57.300 million which missed the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41789256/osisko-gold-royalties-q3-2024-adj-eps-0-15-beats-0-14-estimate-sales-57-300m-miss-59-942m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Osisko Gold Royalties Q3 2024 Adj. EPS $0.15 Beats $0.14 Estimate, Sales $57.300M Miss $59.942M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OR"],"gpt_icon":0},{"id":"2481495251","title":"Osisko Declares Fourth Quarter 2024 Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2481495251","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481495251?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:18","pubTimestamp":1730927880,"startTime":"0","endTime":"0","summary":"MONTREAL, Nov. 06, 2024  -- Osisko Gold Royalties Ltd   is pleased to announce that the Board of Directors has approved a fourth quarter 2024 dividend of C$0.065 per common share. The dividend will be paid on January 15, 2025 to shareholders of record as of the close of business on December 31, 2024. This dividend is an \"eligible dividend\" as defined in the Income Tax Act .For shareholders residing in the United States, the U.S. dollar equivalent will be determined based on the daily rate published by the Bank of Canada on December 31, 2024.Participation in the Plan does not relieve shareholders of any liability for taxes that may be payable in respect of dividends that are reinvested in common shares under the Plan. Shareholders should consult their tax advisors concerning the tax implications of their participation in the Plan having regard to their particular circumstances.This press release is not an offer to sell or a solicitation of an offer to buy any securities in the United St","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Bo2O6ztmIexGmJ_Q.9bseQ--~B/aD04NDt3PTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0f7a1c0737a8622a589763bbad5b6e7d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Bo2O6ztmIexGmJ_Q.9bseQ--~B/aD04NDt3PTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0f7a1c0737a8622a589763bbad5b6e7d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/osisko-declares-fourth-quarter-2024-211800811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OR","BK4017"],"gpt_icon":0},{"id":"2481952542","title":"Osisko Reports Q3 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481952542","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481952542?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:15","pubTimestamp":1730927700,"startTime":"0","endTime":"0","summary":"MONTRAL, Nov. 06, 2024  -- Osisko Gold Royalties Ltd   today announced its consolidated financial results for the third quarter of 2024. Amounts presented are in Canadian dollars, except where otherwise noted.Revenues from royalties and streams of $57.3 million , exclusive of 1,595GEOs earned but not sold due to quarter-end timing;Cash flows generated by operating activities of $47.2 million ;Net earnings of $18.3 million, $0.10 per basic share ;Adjusted earnings4 of $28.8 million, $0.15 per basic share ;Repayment of $27.3 million under the revolving credit facility ;Cash balance of $58.5 million and debt of $80.7 million as at September 30, 2024;Osisko added to the Solactive Global Silver Miners Total Return Index; the underlying index that is tracked by the Global X Silver Miners ETF , pursuant to the index's semi-annual ordinary adjustment, effective November 1, 2024; and,Jason Attew, President & CEO of Osisko commented: “Osisko had a solid third quarter and remains on track to achi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Bo2O6ztmIexGmJ_Q.9bseQ--~B/aD04NDt3PTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0f7a1c0737a8622a589763bbad5b6e7d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Bo2O6ztmIexGmJ_Q.9bseQ--~B/aD04NDt3PTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0f7a1c0737a8622a589763bbad5b6e7d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/osisko-reports-q3-2024-results-211500044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4017","OR"],"gpt_icon":0},{"id":"2481699508","title":"RBC Capital Remains a Buy on Osisko Gold Royalties (OR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481699508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481699508?lang=en_us&edition=fundamental","pubTime":"2024-11-06 09:48","pubTimestamp":1730857684,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Josh Wolfson maintained a Buy rating on Osisko Gold Royalties (OR – Research Report) on November 4 and set a price target of $2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-osisko-gold-royalties-or-8?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-osisko-gold-royalties-or-8?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OR","BK4017","BK4207"],"gpt_icon":0},{"id":"2479037219","title":"Are Basic Materials Stocks Lagging  Osisko Gold Royalties (OR) This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2479037219","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479037219?lang=en_us&edition=fundamental","pubTime":"2024-10-31 21:40","pubTimestamp":1730382011,"startTime":"0","endTime":"0","summary":"Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Has Osisko Gold Royalties  been one of those stocks this year?A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.Osisko Gold Royalties is one of 235 companies in the Basic Materials group. The Basic Materials group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Osisko Gold Royalties is currently sporting a Zacks Rank of #2 .Over the past","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/basic-materials-stocks-lagging-osisko-134011661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4199","OR","SPPJY","BAS","BK4017","BK4588","BK4585","BK4544","ARKG"],"gpt_icon":0},{"id":"2479122132","title":"L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND","url":"https://stock-news.laohu8.com/highlight/detail?id=2479122132","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479122132?lang=en_us&edition=fundamental","pubTime":"2024-10-30 16:12","pubTimestamp":1730275920,"startTime":"0","endTime":"0","summary":"NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA. Clichy, 29 October 2024 – L’Oréal today announces that it has successfully priced a public bond offering for an aggregate nominal amount of 1.25 billion.The offering is composed of two tranches: - A 750 million 3-year fixed rate bond paying a coupon of 2.50 % p.a. - A 500 million 7-year fixed rate bond paying a coupon of 2.875 % p.a.\"This press release does not constitute an offer of sale or solicitation of an offer to purchase L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our website www.loreal-finance.com.This press release may contain forecast information. While the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NeuzJz2hDkAhLRXANB9SUQ--~B/aD0zMzt3PTE0MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0622a14155806a6d4436a82ac8277adf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NeuzJz2hDkAhLRXANB9SUQ--~B/aD0zMzt3PTE0MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0622a14155806a6d4436a82ac8277adf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/l-al-successfully-prices-1-081200192.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["US30Y.BOND","OR","LRLCF","US6M.BOND","BK4104","US5Y.BOND","BK4017","US2Y.BOND","US12M.BOND","AL","BK4585","LRLCY","BK4572","US3Y.BOND","IE0034390439.USD","US7Y.BOND","BK4183","IE00B19Z6F94.USD","BOND","US10Y.BOND","US912797HE00.BOND","BK4588"],"gpt_icon":0},{"id":"2479223993","title":"New data for emapalumab in the treatment of macrophage activation syndrome to be presented at the ACR conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2479223993","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479223993?lang=en_us&edition=fundamental","pubTime":"2024-10-30 15:24","pubTimestamp":1730273040,"startTime":"0","endTime":"0","summary":"STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- Sobi  today announced that new research showing the effect of emapalumab in patients with macrophage activation syndrome  in Still's disease, including systemic juvenile idiopathic arthritis  and adult-onset still's disease  who had an inadequate response to high-dose glucocorticoids  will be presented at the American College of Rheumatology  Convergence in Washington D.C. The data were pooled from two open-label, single-arm interventional studies, the phase 3 NI-0501-14 study [EMERALD; NCT05001737] and NI-0501-06 [NCT03311854], including 39 patients with MAS.\"MAS in Still's disease is a severe condition characterised by intense hyperinflammation and multiple organ failure. Those affected, including young children, often experience high fevers, liver and spleen enlargement, severe cytopenias, and neurological symptoms,\" said Lydia Abad-Franch, MD, Head of Research & Development and Medical Affairs and Chief Medical Officer at Sobi. \"The results ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/C4bAHFteZ8f12t.0SjAj2Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/cfab8d91dd5bce383e31cf1dbde5055b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/C4bAHFteZ8f12t.0SjAj2Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/cfab8d91dd5bce383e31cf1dbde5055b"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/data-emapalumab-treatment-macrophage-activation-072400276.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/data-emapalumab-treatment-macrophage-activation-072400276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4110","SG9999001440.SGD","ACR","BK4588","IE0002270589.USD","HSCT","BK4086","IE00B19Z3B42.SGD","BK4139","LU0868494617.USD","MAS","LU0289739699.SGD","LU1059921491.USD","LU1261432733.SGD","IE00B19Z3581.USD","LU0170899867.USD","BK4017","OR","IE00BSNM7G36.USD","LU0058720904.USD","BIOVF","CI","SWOBY","BK4196"],"gpt_icon":0},{"id":"2479940657","title":"HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS","url":"https://stock-news.laohu8.com/highlight/detail?id=2479940657","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479940657?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:30","pubTimestamp":1730201400,"startTime":"0","endTime":"0","summary":"WAKIX  Net Revenue of $186.0 Million for Third Quarter 2024; Surpassed $2B in Cumulative Net Revenue in Less Than Five Years. On Track to Submit sNDA for Pitolisant in Idiopathic Hypersomnia  in Q4 2024 Based on Updated Strong and Sustained Efficacy Data from Long-Term Extension Study. Next-Gen Pitolisant-GR and Pitolisant-HD Programs Advance; IND for Potential Best-In-Class, Novel Orexin-2 Agonist On Track for mid-2025, Extending Leadership in Sleep/Wake Beyond 2040s. Highlights Most Advanced Development Program and Proven Serotonergic  Mechanism of Action For EPX-100 in Rare Epilepsies; Pivotal Phase 3 Trial in Dravet Syndrome Ongoing; Phase 3 Registrational Trial in Lennox-Gastaut Syndrome to Initiate Before Year End. Next Major Clinical Catalyst: Topline Data From ZYN-002 Pivotal Phase 3 RECONNECT Trial in Fragile X Syndrome on Track For mid-2025. Reiterates 2024 Net Product Revenue Guidance of $700 - $720 Million. Conference Call and Webcast to be Held Today at 8:30 a.m. ET","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GxeBcdJw4y0ZK5v3pMgmpA--~B/aD0yOTM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f7db46efb59308fee209dd80bac82676","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GxeBcdJw4y0ZK5v3pMgmpA--~B/aD0yOTM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f7db46efb59308fee209dd80bac82676"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/harmony-biosciences-reports-strong-third-113000420.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/harmony-biosciences-reports-strong-third-113000420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4017","HRMY","NEXT","ODD","YEAR","BK4007","FIVE","ESS","FXS","OR","IH","BK4510","SSI","BK4085","BK4215","MORE","BK4585","BK4588","BK4183","BK4144","BK4563","BK4200"],"gpt_icon":0},{"id":"2479849253","title":"RBC Capital Remains a Buy on Osisko Gold Royalties (OR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479849253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479849253?lang=en_us&edition=fundamental","pubTime":"2024-10-29 09:48","pubTimestamp":1730166513,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Josh Wolfson from RBC Capital maintained a Buy rating on Osisko Gold Royalties (OR – Research Report), with a price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-osisko-gold-royalties-or-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-osisko-gold-royalties-or-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","OR","BK4017"],"gpt_icon":0},{"id":"2478954095","title":"Why Osisko Gold (OR) is Poised to Beat Earnings Estimates Again","url":"https://stock-news.laohu8.com/highlight/detail?id=2478954095","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478954095?lang=en_us&edition=fundamental","pubTime":"2024-10-26 00:10","pubTimestamp":1729872608,"startTime":"0","endTime":"0","summary":"When looking at the last two reports, this mining royalty and exploration company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 8.71%, on average, in the last two quarters.For the most recent quarter, Osisko Gold was expected to post earnings of $0.12 per share, but it reported $0.13 per share instead, representing a surprise of 8.33%. For the previous quarter, the consensus estimate was $0.11 per share, while it actually produced $0.12 per share, a surprise of 9.09%.Thanks in part to this history, there has been a favorable change in earnings estimates for Osisko Gold lately. In fact, the Zacks Earnings ESP  for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.Want the latest recommendations from Zacks Investment Research?Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-osisko-gold-poised-beat-161008547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.osiskogr.com","stockEarnings":[{"period":"1week","weight":0.0683},{"period":"1month","weight":-0.0588},{"period":"3month","weight":0.1139},{"period":"6month","weight":0.2229},{"period":"1year","weight":0.4257},{"period":"ytd","weight":0.3908}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Osisko Gold Royalties Ltd acquires and manages precious metal and other royalties, streams, and other interests in Canada and internationally. It also owns options on offtake; royalty/stream financings; and exclusive rights to participate in future royalty/stream financings on various projects. The company's primary asset is a 5% net smelter return royalty on the Canadian Malartic mine located in Canada. In addition, it is involved in the exploration, evaluation, and development of mining projects. It primarily explores for precious metals, including gold, silver, diamond, and others. The company is based in Montreal, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.019896},{"month":2,"riseRate":0.375,"avgChangeRate":-0.022196},{"month":3,"riseRate":0.75,"avgChangeRate":0.05239},{"month":4,"riseRate":0.625,"avgChangeRate":0.024943},{"month":5,"riseRate":0.5,"avgChangeRate":0.024487},{"month":6,"riseRate":0.375,"avgChangeRate":-0.017889},{"month":7,"riseRate":0.75,"avgChangeRate":0.059917},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.043465},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.059705},{"month":10,"riseRate":0.666667,"avgChangeRate":0.028526},{"month":11,"riseRate":0.222222,"avgChangeRate":0.004869},{"month":12,"riseRate":0.5,"avgChangeRate":0.043002}],"exchange":"NYSE","name":"Osisko Gold Royalties","nameEN":"Osisko Gold Royalties"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Osisko Gold Royalties(OR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Osisko Gold Royalties(OR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Osisko Gold Royalties,OR,Osisko Gold Royalties股票,Osisko Gold Royalties股票老虎,Osisko Gold Royalties股票老虎国际,Osisko Gold Royalties行情,Osisko Gold Royalties股票行情,Osisko Gold Royalties股价,Osisko Gold Royalties股市,Osisko Gold Royalties股票价格,Osisko Gold Royalties股票交易,Osisko Gold Royalties股票购买,Osisko Gold Royalties股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Osisko Gold Royalties(OR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Osisko Gold Royalties(OR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction